» Articles » PMID: 15928208

Gene Expression and Phenotypic Characterization of Mouse Heart After Chronic Constant or Intermittent Hypoxia

Overview
Date 2005 Jun 2
PMID 15928208
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic constant hypoxia (CCH), such as in pulmonary diseases or high altitude, and chronic intermittent hypoxia (CIH), such as in sleep apnea, can lead to major changes in the heart. Molecular mechanisms underlying these cardiac alterations are not well understood. We hypothesized that changes in gene expression could help to delineate such mechanisms. The current study used a neonatal mouse model in CCH or CIH combined with cDNA microarrays to determine changes in gene expression in the CCH or CIH mouse heart. Both CCH and CIH induced substantial alterations in gene expression. In addition, a robust right ventricular hypertrophy and cardiac enlargement was found in CCH- but not in CIH-treated mouse heart. On one hand, upregulation in RNA and protein levels of eukaryotic translation initiation factor-2alpha and -4E (eIF-2alpha and eIF-4E) was found in CCH, whereas eIF-4E was downregulated in 1- and 2-wk CIH, suggesting that eIF-4E is likely to play an important role in the cardiac hypertrophy observed in CCH-treated mice. On the other hand, the specific downregulation of heart development-related genes (e.g., notch gene homolog-1, MAD homolog-4) and the upregulation of proteolysis genes (e.g., calpain-5) in the CIH heart can explain the lack of hypertrophy in CIH. Interestingly, apoptosis was enhanced in CCH but not CIH, and this was correlated with an upregulation of proapoptotic genes and downregulation of anti-apoptotic genes in CCH. In summary, our results indicate that 1) the pattern of gene response to CCH is different from that of CIH in mouse heart, and 2) the identified expression differences in certain gene groups are helpful in dissecting mechanisms responsible for phenotypes observed.

Citing Articles

Theory and Applications of the (Cardio) Genomic Fabric Approach to Post-Ischemic and Hypoxia-Induced Heart Failure.

Iacobas D, Xi L J Pers Med. 2022; 12(8).

PMID: 36013195 PMC: 9410512. DOI: 10.3390/jpm12081246.


MKRN1 Ubiquitylates p21 to Protect against Intermittent Hypoxia-Induced Myocardial Apoptosis.

Bai X, Yang H, Pu J, Zhao Y, Jin Y, Yu Q Oxid Med Cell Longev. 2021; 2021:9360339.

PMID: 34504644 PMC: 8423574. DOI: 10.1155/2021/9360339.


Microbiota Modulates Cardiac Transcriptional Responses to Intermittent Hypoxia and Hypercapnia.

Zhou D, Xue J, Miyamoto Y, Poulsen O, Eckmann L, Haddad G Front Physiol. 2021; 12:680275.

PMID: 34248668 PMC: 8267877. DOI: 10.3389/fphys.2021.680275.


A Personalized Genomics Approach of the Prostate Cancer.

Iacobas S, Iacobas D Cells. 2021; 10(7).

PMID: 34209090 PMC: 8305988. DOI: 10.3390/cells10071644.


Roxadustat as treatment for a blood transfusion-dependent maintenance hemodialysis patient: A case report and review of literature.

Fei M, Wen X, Yu Z, Kang T, Wu W, Ou S World J Clin Cases. 2021; 9(15):3680-3688.

PMID: 34046470 PMC: 8130086. DOI: 10.12998/wjcc.v9.i15.3680.


References
1.
Neubauer S, Remkes H, Spindler M, Horn M, Wiesmann F, Prestle J . Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure. Circulation. 1999; 100(18):1847-50. DOI: 10.1161/01.cir.100.18.1847. View

2.
Pierson D . Pathophysiology and clinical effects of chronic hypoxia. Respir Care. 2000; 45(1):39-51; discussion 51-3. View

3.
Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

4.
Vanderklish P, Bahr B . The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states. Int J Exp Pathol. 2001; 81(5):323-39. PMC: 2517738. DOI: 10.1111/j.1365-2613.2000.00169.x. View

5.
Kerr M, Churchill G . Statistical design and the analysis of gene expression microarray data. Genet Res. 2001; 77(2):123-8. DOI: 10.1017/s0016672301005055. View